Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online June 1, 2019.
Copyright & Usage
Copyright © 2019 The Cleveland Clinic Foundation. All Rights Reserved.
Author Information
- Erika Hutt Centeno, MD⇑
- Department of Internal Medicine, Cleveland Clinic
- Clinical Instructor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
- ADDRESS:
Erika Hutt Centeno, MD, Department of Internal Medicine, G10, Cleveland Clinic; 9500 Euclid Avenue, Cleveland, OH, 44195; huttcee{at}ccf.org
Cited By...
Jump to section
- Article
- ABSTRACT
- UNFRACTIONATED HEPARIN AND WARFARIN ARE STILL WIDELY USED
- UNFRACTIONATED HEPARIN’S EFFECT IS UNPREDICTABLE
- MONITORING UNFRACTIONATED HEPARIN IMPROVES OUTCOMES
- THE aPTT REFLECTS THROMBIN INHIBITION
- HEPARIN ASSAYS MEASURE UNFRACTIONATED HEPARIN ACTIVITY
- ANTI-Xa ASSAY VS THE aPTT
- CLINICAL APPLICABILITY OF THE ANTI-Xa ASSAY
- LIMITATIONS OF ANTI-Xa ASSAYS
- ANTI-Xa ASSAYS AND LOW-MOLECULAR-WEIGHT HEPARINS
- ANTI-Xa ASSAYS IN PATIENTS RECEIVING DIRECT ORAL ANTICOAGULANTS
- REFERENCES
- Figures & Data
- Info & Metrics